Russia is responsible for 25 key crude and natural gas projects expected to commence operations by 2025, dominating the Former Soviet Union’s (FSU) oil and gas production. The two other key planned projects in the FSU region are in Kazakhstan, led by the colossal Kashagan crude oil project, which is thought to be the world’s largest discovery in the last 30 years. Russia will account for most of the planned oil and gas production in the FSU, with Gazprom contributing the highest oil and gas production in the region by 2025.
GlobalData’s Production and Capital Expenditure Outlook for Key Planned Upstream Projects in Countries of the Former Soviet Union report provides analysis on oil and gas production by key countries and companies in the Former Soviet Union (FSU) region from 2016 to 2025. It includes detailed information on the number of planned projects and their start dates by key countries and companies in the FSU region, as well as information on their capital expenditures.
Single User Price: $1,500
Market value: The global generics market grew by 9.1% in 2015 to reach a value of $271.2 billion. In 2020, the global generics market is forecast to have a value of $412.9 billion, an increase of 52.3% since 2015.
Market volume: The global generics market grew by 2% in 2015 to reach a volume of 82.2 % of total pharma volume. In 2020, the global generics market is forecast to have a volume of 88.7 % of total pharma volume, an increase of 7.9% since 2015.
Geography segmentation: Asia-Pacific accounts for 34.8% of the global generics market value.
MarketLine’s latest report Generics: Global Industry Guide, provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The guide also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Your key questions answered
– What was the size of the global generics market by value in 2015?
– What will be the size of the global generics market in 2020?
– What factors are affecting the strength of competition in the global generics market?
– How has the market performed over the last five years?
– How large is the global generics market in relation to its regional counterparts?
Single user price: $1,495
Market value: The global electricity retailing market grew by 7.6% in 2015 to reach a value of $2,561.4 billion. In 2020, the global electricity retailing market is forecast to have a value of $3,545.1 billion, an increase of 38.4% since 2015.
Market volume: The global electricity retailing market grew by 4.6% in 2015 to reach a volume of 19,744.1 TWh. In 2020, the global electricity retailing market is forecast to have a volume of 23,367.5 TWh, an increase of 18.4% since 2015.
Category segmentation: Industrial is the largest segment of the global electricity retailing market, accounting for 38% of the market’s total volume.
Geography segmentation: Asia-Pacific accounts for 45.2% of the global electricity retailing market value.
Market share: Korea Electric Power Corporation is the leading player in the global electricity retailing market, generating a 2.5% share of the market’s volume.
MarketLine’s latest report Electricity Retailing: Global Industry Guide provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2011-15, and forecast to 2020). The guide also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Your key questions answered
- What was the size of the global electricity retailing market by value in 2015?
- What will be the size of the global electricity retailing market in 2020?
- What factors are affecting the strength of competition in the global electricity retailing market?
- How has the market performed over the last five years?
- Who are the top competitors in the global electricity retailing market?
Single user price: $1,495
- A total of 65 FPSOs are expected to commence operations by the year 2020. However the start of the several planned FPSOs is estimated to be delayed due to declining upstream capital expenditure.
- In the global FPSO industry, South America will have the highest planned FPSO additions by 2020 (19 FPSOs), followed by Africa and Europe with 13 and 12 FPSOs respectively.
- Among countries Brazil will have the highest planned deployment of FPSOs, both at the global level as well as in South America. The country is expected to deploy 18 FPSOs by 2020 when compared to 17 FPSOs in the last quarter.
- UK, Angola and Nigeria will be the other leading countries in the world for the planned deployment of FPSOs.
- Petroleo Brasileiro S.A. will drive the FPSO industry in Brazil with planned deployment of 19 FPSOs by 2020.
- Among companies, Chevron, Royal Dutch Shell, Bumi Armada and Teekay will be the other leading FPSO operators in the world.
- In Africa, Angola, Nigeria and Ghana will drive the FPSO industry. The three countries are expected to deploy six, four and two FPSOs respectively by 2020.
- In Europe, FPSOs will be primarily deployed in offshore projects in the North Sea and Barents Sea. UK will lead the region with planned deployment of eight FPSOs by 2020.
- In the remaining regions such as Asia and North America, seven and three FPSOs are expected to start operations by 2020. In the Middle East and Oceania, two FPSOs are expected to start operations in each of the regions.
GlobalData’s latest report Q1 2016 Global FPSO Industry Outlook – Decline in Capital Expenditure Spending Continues to Delay Planned FPSO Deployments provides an in-depth overview on the global FPSO industry. It provides data of FPSOs that were brought online from 2010 to 2015 by key regions in the world, with forecasts up to 2020, by key countries and operators. It also includes details of major planned FPSOs in the world up to 2020 with recent developments, tenders and contracts by key regions, where available.
Single user price: $1,500
- Global Ammonia capacity will experience considerable growth in the next five years, increasing from 224.9 mmtpa in 2015 to 270.4 mmtpa in 2020. Around 79 planned projects are slated to come online in the next five years, driven primarily by the US, Iran and Russia.
- Two new ammonia projects were announced since the last report published in October 2015.The new ammonia projects announced were Grannus LLC Kern County Ammonia project and Riaba Fertilizers Limited Riaba Ammonia project.
- The US has 14 planned ammonia projects with a total capacity of 8.0 mmtpa, slated to come online by 2020 with a capital expenditure of US$3.0 billion. CF Industries Holdings, Inc. and Incitec Pivot Limited are the top companies accounting for major capacity additions in the US.
- Iran has 12 planned ammonia projects, adding a capacity of 7.4 mmtpa by 2018. Iran’s capital expenditure will be US$3.2 billion over the next five years. Major capacity additions will be from The National Petrochemical Company in Iran.
- In Europe, major ammonia capacity additions are from Russia, adding a capacity of about 4.2 mmtpa by 2018, planning to spend capex of around US$2.4 billion over the next five years. Eurochem Mineral and Chemical Co and PhosAgro holding company are the top two companies accounting for major capacity addition in Russia.
- India and china are the top two countries in Asia adding ammonia capacity of about 6.2 mmtpa in the next five years, planning to spend capital expenditure of US$4.3 billion over the next five years. Africa is expected to shell around US$3.1 billion to add a capacity of about 8.0 mmtpa, expected to come onstream by 2020.
- In South America, Peru and Brazil are the top two countries adding ammonia capacity of about 1.6 mmtpa by 2018.In Oceania, Australia will spend US$ 0.06 billion to add 1.2 mmtpa of capacity, expected onstream by 2016.
GlobalData’s latest report Q1 Global Ammonia Capacity and Capital Expenditure Outlook – CF Industries and Dangote Lead Ammonia Capacity Growth, provides information and insight on historic and forecast global ammonia capacity by region. The report includes capacity share of the major ammonia producers in the world, global ammonia capital expenditure forecast by region, capacity by feedstock and planned plants details.
Single user price: $1,500
Urine Analyzers are automated or semi automated analytical laboratory equipments used in qualitative and semi-quantitative tests. It is performed on urine samples to determine specific contents of chemicals and proteins in the body. These tests are generally done to determine the content of glucose, protein pH, leukocytes, nitrites, ketones, bilirubin, blood, urobilinogen, specific gravity etc. in the sample. GlobalData’s Medical Devices sector report, “Urine Analyzers – Medical Devices Pipeline Assessment, 2016” provides comprehensive information about the Urine Analyzers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Single user price: $2,500
Mexico Polypropylene plant capacity has increased from 0.220 MMTPA in 2005 to 0.590 MMTPA in 2014, at a CAGR of 11.6%. It is expected to remain the same as 0.590 MMTPA until 2019. Private companies dominate the Polypropylene sector in Mexico. The major companies in the region are Grupo Alfa and LyondellBasell Industries N.V.. Together these companies accounted for 100.0% of the Polypropylene capacity in Mexico in 2014.
GlobalData’s report, Polypropylene Industry Outlook in Mexico to 2019 – Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides up to date in-depth information on Mexico’s Polypropylene industry. The report presents major market trends. The report covers Mexico’s Polypropylene plants and presents installed capacity by production process and technology. The report offers historical and forecast market size, demand and production forecasts, end-use demand details, price trends, trade balance data, and company shares of the country’s leading Polypropylene producers.
Single User Price: $1,000
The Asia-Pacific (APAC) Alzheimer’s Disease (AD) market is forecast to grow from $3 billion in 2014 to $5.1 billion in 2021 at a CAGR of 7.9%. Over the forecast period the prevalence of AD and Mild Cognitive Impairment (MCI) is expected to increase across the APAC markets, mainly due to an aging population, as the disease is more common among the elderly. The rising prevalence population, together with better diagnostic techniques, improving health awareness, special healthcare programs for elderly populations, health insurance coverage and increasing affordability, especially in India and China, will increase diagnosis and the treatment-receiving population, driving demand and contributing to market growth. However, incidence of AD and MCI is notably lower in Asia than in western countries. AD is more common in industrialized, western countries than in Asia. The incidence of AD and MCI is low in Asia due to a lower life expectancy than in western countries. Moreover, people who live in Asia have protective factors against AD which have not been explored completely, leading to the disease being less prevalent in these countries.
GBI Research’s Alzheimer’s Therapeutics in Asia-Pacific Markets to 2021 – Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Disease Modifying Therapies report provides analysis of the Alzheimer’s disease treatment space across the Asia-Pacific countries of India, China, Australia and Japan, with annualized market date from 2014 and forecast to 2021. It includes analysis of the Alzheimer’s disease pipeline stratified by stage of development, molecule type, and molecular target.
Single User Price: $4,995
Global annual installations increased considerably to 48.67 GW in 2015, due to a rise of installations in China, Japan, the US and India. China became the largest consumer of solar Photovoltaic (PV) modules in 2015 – overtaking Japan and the US. Annual installations in China grew from 500 Megawatts (MW) in 2010, to 18.43 GW in 2015, while Japan and the US held the second and third largest annual installations, with around 10 GW and 6.2 GW respectively. China held around 30% of the world’s crystalline silicon (c-Si) installed capacity share, followed by Japan with a 25% share, while in the thin-film market the US contributed to about 40% of the world’s installed capacity, followed by Japan with a 31% share. Annual additions grew moderately in the US and Japan, while they fell sharply in Italy and Germany.
GlobalData’s latest report Solar PV Module Market, Update 2015 – Market Size, Average Price, Market Share and Key Country Analysis to 2020 provides detailed information on the current solar PV module market, focusing on key countries as well as the global scenario. The report analyses annual module installation trends, module production volume and capacity, module production share, average module price and market size for global and key countries.
Single user price: $3,995
The pharmaceutical sector is one of the most dynamic industries in the UK and is a major contributor to the country’s economy. The pharmaceutical market in the UK is set to grow from $28.8 billion in 2015 to approximately $43 billion by 2020, representing a Compound Annual Growth Rate (CAGR) of 8.4%, driven primarily by a robust life sciences industry. The pharmaceutical industry was the sixth largest contributor to the UK’s balance of trade, contributing $46.9 billion (£32.4 billion) to the economy in 2014, according to the Association of the British Pharmaceutical Industry.
GlobalData’s CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – UK report provides analysis of the pharmaceutical market landscape in the UK, and the impact of the current and emerging market access strategies used by the pharmaceutical industry for new and existing drugs. It discusses the regulatory requirements, key health insurance trends, government healthcare policies, and general industry trends.
Single User Price: $1,995